# Effect of E Balance Pro Therapy on Diabetes and Related Complications

> **NCT03172260** · — · COMPLETED · sponsor: **CellMedX Corporation** · enrollment: 31 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DEVICE:** E Balance Pro Therapy

## Key facts

- **NCT ID:** NCT03172260
- **Lead sponsor:** CellMedX Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-08
- **Primary completion:** 2017-07-20
- **Final completion:** 2017-07-20
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03172260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03172260, "Effect of E Balance Pro Therapy on Diabetes and Related Complications". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03172260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*